BioCentury
ARTICLE | Clinical News

DPX-RSV: Additional Ph I data

April 14, 2017 4:33 PM UTC

Data from 7 healthy volunteers in a double-blind, placebo-controlled, Canadian Phase I trial showed that 25 µg intramuscular DPX-RSV led to an antigen-specific antibody response that was maintained at...

BCIQ Company Profiles

IMV Inc.